Correction to “Triply Enhanced Immunotherapy via Dual Glycan Reforming Integrated with Perforation”

Pages 3, 6 and 7. We noticed misuses of the CLSM images in Figure 2b line 3 for SLO-Gal and Figure 4f lines 1 and 4 for Control and SLO-Gal&SLO-NEU, respectively, and the H&E staining image in Figure 5e line 1 column 4 for SLO@HA.Pages 7 and 12 in Supporting Information.There are misuses of the CLSM images in Figure S3c lines 2 and 3 for GD and GD+SLO, respectively, and the H&E staining images in Figure S14 line 1 columns 4, 6 and 7 for SLO@HA, SLO-NEU@HA and TEID respectively, line 2 column 7 for TEID, line 3 column 7 for TEID, line 4 columns 6 and 7 for SLO-NEU@HA and TEID respectively, and line 5 column 4 for SLO@HA.These images need to be corrected, but the results and conclusions in the published Article are not changed.The corrected Figures 2, 4 and 5 are presented below.Figures S3 and S14 have been corrected in the updated Supporting Information.